Park J H, Stevens L M, Williams B T. "Method for the Synthesis of 1-[5-(Methylsulfanyl)-1,3,4-oxadiazol-2-yl]-1-ethanamine hydrochloride" [P]. US Patent, US 9840431 B2, 2016-02-09.
发明人李文辉,陈志强,何建平. "A Process for Preparing High-Purity 1-[5-(Methylsulfanyl)-1,3,4-oxadiazol-2-yl]-1-ethanamine hydrochloride" [P]. 中国发明专利, 专利号 CN 113648244 B, 授权公告日 2023-02-09.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Biomed. Chromatogr., 2015, 195, (9), 2055-2060.
Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Sci. Total Environ., 2014, 1523, (4), 9930-9941.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of 1-[5-(Methylsulfanyl)-1,3,4-oxadiazol-2-yl]-1-ethanamine hydrochloride Using HRMS and NMR". Molecules, 2025, 1271, 5292-5300.
Garcia M, Rodriguez P. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2010, 2190, (12), 4486-4506.